41167-58-2

Basic information

• Product Name: METHYL (2Z)-2-HYDROXY-4-OXO-4-PHENYLBUT-2-ENOATE
• Synonyms: ART-CHEM-BB B024732;METHYL (2Z)-2-HYDROXY-4-OXO-4-PHENYLBUT-2-ENOATE;AKOS B024732;2-BUTENOIC ACID, 2-HYDROXY-4-OXO-4-PHENYL-, METHYL;2-HYDROXY-4-OXO-4-PHENYL-BUT-2-ENOIC ACID METHYL ESTER;(E)-methyl 2-hydroxy-4-oxo-4-phenylbut-2-enoate
• CAS NO: 41167-58-2
• Molecular Formula: C₁₁H₁₀O₄
• Molecular Weight: 206.19
• Mol File: 41167-58-2.mol
• Article Data: 15

Chemical Properties

• Melting Point: 56-57 °C
• Boiling Point: 336.1±42.0 °C(Predicted)
• Appearance: /
• Density: 1.250±0.06 g/cm3(Predicted)
• PKA: 8.07±0.50(Predicted)
• CAS DataBase Reference: METHYL (2Z)-2-HYDROXY-4-OXO-4-PHENYLBUT-2-ENOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL (2Z)-2-HYDROXY-4-OXO-4-PHENYLBUT-2-ENOATE(41167-58-2)
• EPA Substance Registry System: METHYL (2Z)-2-HYDROXY-4-OXO-4-PHENYLBUT-2-ENOATE(41167-58-2)

Safety Data

• Hazardous Substances Data: 41167-58-2(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 124-41-4 sodium methylate 
• 98-86-2 acetophenone 
• 95-92-1 oxalic acid diethyl ester 
• 553-90-2 Dimethyl oxalate 

Downstream Products

• 5817-92-5 2,4-dioxo-4-phenylbutanoic acid 
• 1391501-91-9 C₂₅H₂₄BrN₃O₃ 
• 1391501-92-0 4-benzoyl-5-(4-bromophenyl)-1-[3-(1H-imidazol-1-yl)propyl]-3-(propan-2-yloxy)-2,5-dihydro-1H-pyrrol-2-one 
• 1391501-93-1 C₂₈H₃₀BrN₃O₃ 
• 1391501-94-2 C₂₇H₂₈BrN₃O₃ 
• 1391501-95-3 C₂₉H₃₀BrN₃O₃ 
• 1391501-97-5 C₃₀H₂₆BrN₃O₃ 
• 1391502-00-3 4-benzoyl-5-(4-bromophenyl)-1-[3-(1H-imidazol-1-yl)propyl]-3-(2-methoxyethoxy)-2,5-dihydro-1H-pyrrol-2-one 
• 1391502-02-5 C₂₆H₂₆BrN₃O₃ 
• 1391501-64-6 C₂₃H₂₁BrN₄O₂ 
• 1391501-89-5 C₂₉H₂₅BrN₄O₂ 
• 1391501-68-0 C₃₀H₂₇BrN₄O₂ 
• 1391501-72-6 C₃₁H₂₉BrN₄O₃ 
• 1391501-70-4 C₂₉H₂₄BrFN₄O₂ 

Relevant articles and documents

Synthesis of Functionalized Cyclobutenes and Spirocycles via Asymmetric P(III)/P(V) Redox Catalysis

An enantioselective phosphine-catalyzed transformation has been developed for the synthesis of chiral cyclobutene triesters and fluorinated spirocyclic compounds. The strategy involved a P(III)/P(V) redox cycling process, via in situ reduction of phosphin

Pyrrole and pyrazole compound of preparation and use as medicaments (by machine translation)

The invention relates to the field of medical technology, this invention has offered a kind of sulfonamide and nitrogen mixed uncle butane pyrrole and pyrazole compound, including optical isomers, racemic modification, and any combination of the trans isomer or a pharmaceutically acceptable salt thereof, having a structure of formula (I); the invention also provides the preparation method of the compound and its application, in particular in the preparation of anti-tumor drug application. (by machine translation)

Diacylhydrazines derivative containing indole skeleton as well as preparation method and application thereof

The invention discloses a diacylhydrazines derivative containing an indole skeleton as well as a preparation method and application thereof. A structure of the diacylhydrazines derivative containing the indole skeleton disclosed by the invention is shown in a formula: the formula (1) is shown in the description, wherein R1 is selected from -H and -F; R2 is selected from -H and -Br; R3 is selectedfrom -H, -Cl and -I; R4 is selected from -CH3, -Cl, -H, -F and -CF3. A synthetic method of the diacylhydrazines derivative has the advantages of simple process, less steps, lower cost, high efficiencyand convenience and has good universality, and moreover, the diacylhydrazines derivative can be produced in batch.